Abstract
Although #infective is a relatively rare infectious disease it remains
a potentially lethal disease with a high morbidity and mortality rate
despite medical and surgical advances. Furthermore, the best treatment
and timing are often debate. We present the case of a young man with
drug addiction and hepatitis B and C, who clinically presented with
acute fever, #dyspnea, severe anemia and #hemoptysis. Acute tricuspid and
aortic valve endocarditis by S. Aureus was clinically and
#echocardiography diagnosed and an early surgical treatment by aortic and
tricuspid valve replacement by BioAorticTM and BioMitralTM prosthesis
was successfully chosen.Even if Infective endocarditis (IE) is relatively rare with an annual
increasing incidence ranging from 10 to 15 per 100 000 person-years, it
carries a high rate of morbidity and mortality [1]. Medical treatment
and targeted antibiotic therapy are the first line treatment and should
begin as soon as possible. Usually isolated rightside heart IE (RSE)
have better outcomes compared to left (LSE) or right and left sides
infection (RLSE) [2] and even if the #antibiotic therapy should be
completed, in some cases, like huge vegetations or persistent infection
with high fever or uncontrolled systemic #compromission, early surgery is
recommended to prevent life-threatening complications [3].
For more articles on BJSTR Journal please click on https://biomedres.us/
For more Cancer Medicine Articles on BJSTR
Early Treatment of Acute Infective Tricuspid and Aortic Valve Active Endocarditis: The �Bio� Solution by Saitto G in BJSTR
Follow on Twitter : https://twitter.com/Biomedres01
Follow on Tumbler: https://biomedres.tumblr.com/
Like Our Pins On : https://www.pinterest.com/biomedres/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.